RPG LIFE SCIENCES share price has zoomed 12% and is presently trading at Rs 2,010.0.
Meanwhile, the BSE HEALTHCARE index is at 38,181.4 (up 0.1%).
Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 2.4%) and SUVEN PHARMACEUTICALS (up 1.2%).
Jubilant Pharmova (down 2.9%) and ASTER DM HEALTHCARE (down 1.5%) are among the top losers today.
Over the last one year, RPG LIFE SCIENCES has moved up from Rs 968.9 to Rs 2,010.0, registering a gain of Rs 1,041.1 (up 107.5%).
On the other hand, the BSE HEALTHCARE index has moved up from 26,342.4 to 38,181.4, registering a gain of 44.9% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 92.8%), Cadila Healthcare (up 92.0%) and Lupin (up 91.0%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 80,402.7 (down 0.3%).
The top losers among the BSE Sensex today are Kotak Bank (down 3.3%) and Reliance Ind. (down 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.
In the meantime, NSE Nifty is at 24,487.8 (down 0.2%). Wipro and Kotak Bank are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,795.1 to 80,402.7, registering a gain of 13,607.6 points (up 20.4%).
RPG LIFE SCIENCES net profit grew 21.1% YoY to Rs 268 million for the quarter ended June 2024, compared to a profit of Rs 221 million a year ago. Net sales rose 11.9% to Rs 1,654 million during the period as against Rs 1,478 million in April-June 2023.
For the year ended March 2024, RPG LIFE SCIENCES reported 29.6% increase in net profit to Rs 877 million compared to net profit of Rs 676 million during FY23. Revenue of the company grew 13.5% to Rs 5,821 million during FY24.
The current Price to earnings ratio of RPG LIFE SCIENCES, based on rolling 12 month earnings, stands at 36.0.
Equitymaster requests your view! Post a comment on "RPG LIFE SCIENCES Gains 12%; BSE HEALTHCARE Index Up 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!